Meloxicam temporally inhibits the expression of vascular endothelial growth factor receptor (VEGFR)-1 and VEGFR-2 during alveolar bone repair in rats. [electronic resource]
Producer: 20160322Description: 162-72 p. digitalISSN:- 1943-3670
- Alveolar Process -- drug effects
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Bone Density -- drug effects
- Bone Remodeling -- drug effects
- Cyclooxygenase 2 Inhibitors -- pharmacology
- Down-Regulation
- Isoenzymes -- antagonists & inhibitors
- Male
- Maxilla -- drug effects
- Meloxicam
- Osteoclasts -- pathology
- Osteogenesis -- drug effects
- Rats
- Rats, Wistar
- Signal Transduction -- drug effects
- Thiazines -- pharmacology
- Thiazoles -- pharmacology
- Time Factors
- Tooth Socket -- drug effects
- Vascular Endothelial Growth Factor A -- drug effects
- Vascular Endothelial Growth Factor Receptor-1 -- drug effects
- Vascular Endothelial Growth Factor Receptor-2 -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.